| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.00086 | 1 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.00079 | 1 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.00078 | 1 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.00053 | 1 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.00044 | 1 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00049 | 1 |